China Universal Asset Management Co., Ltd. Foghorn Therapeutics Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$5.0 - $9.87 $2,625 - $5,181	525 Added 95.8%	1,073 $5,000
Q3 2023 Oct 30, 2023	BUY	$5.0 - $9.87 $2,625 - $5,181	525 Added 95.8%	1,073 $5,000
Q2 2023 May 21, 2024	SELL	$5.37 - $8.84 $96 - $159	-18 Reduced 3.18%	548 $3,000
Q2 2023 Jul 27, 2023	SELL	$5.37 - $8.84 $96 - $159	-18 Reduced 3.18%	548 $4,000
Q1 2023 May 21, 2024	BUY	$4.66 - $8.99 $657 - $1,267	141 Added 33.18%	566 $3,000
Q1 2023 Apr 27, 2023	BUY	$4.66 - $8.99 $657 - $1,267	141 Added 33.18%	566 $4,000
Q4 2022 May 21, 2024	BUY	$5.44 - $9.46 $2,312 - $4,020	425 New	425 $2,000
Q4 2022 Jan 31, 2023	BUY	$5.44 - $9.46 $2,312 - $4,020	425 New	425 $3,000

Others Institutions Holding FHTX

# of Institutions

Shares Held

32.7M

Call Options Held

Put Options Held

1.8K

Flagship Pioneering Inc. Cambridge, MA

12.7M
Shares

$102 Million
8.71% of portfolio
Bvf Inc San Francisco, CA

5.3M
Shares

$42.8 Million
0.93% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

2.52M
Shares

$20.3 Million
0.3% of portfolio
Raymond James & Associates St Petersburg, FL

2.3M
Shares

$18.5 Million
0.01% of portfolio
Euclidean Capital LLC New York, NY

1.57M
Shares

$12.7 Million
1.14% of portfolio

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $336M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account